{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:13:31Z","timestamp":1775646811893,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12032-018-1183-7","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T12:18:23Z","timestamp":1533212303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization"],"prefix":"10.1007","volume":"35","author":[{"given":"Matteo","family":"Sbattella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Zanichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Suffritti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Teatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-7690","authenticated-orcid":false,"given":"Roberto","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"issue":"3","key":"1183_CR1","doi-asserted-by":"publisher","first-page":"323332","DOI":"10.1016\/j.critrevonc.2013.02.004","volume":"87","author":"R Castelli","year":"2013","unstructured":"Castelli R, Zanichelli A, Cicardi M, et al. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship. Crit. Rev. Oncol. Hematol. 2013;87(3):323\u2013332.","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"1183_CR2","first-page":"181190","volume":"35","author":"R Castelli","year":"2013","unstructured":"Castelli R, Zanichelli A, Cugno M. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic. Imm unopharmacol. Immunotoxicol. 2013;35:181\u2013190","journal-title":"Immunotoxicol"},{"key":"1183_CR3","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/cea.12293","volume":"44","author":"C Suffritti","year":"2014","unstructured":"Suffritti C, Zanichelli A, Maggioni L, et al. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Clin Exp Allergy. 2014;44:1503\u201314.","journal-title":"Clin Exp Allergy"},{"key":"1183_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/MBC.0b013e3283494ba7","volume":"22","author":"S Caccia","year":"2011","unstructured":"Caccia S, Castelli R, Maiocchi D, et al. Interaction of C1 inhibitor with thrombin on the endothelial surface. Blood Coagul Fibrinolysis. 2011;22:571\u20135.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"1183_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.autrev.2008.05.003","volume":"8","author":"M Cugno","year":"2008","unstructured":"Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmun. Rev. 2008;8(2) 156\u2013159.","journal-title":"Autoimmun. Rev"},{"key":"1183_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjh.13908","volume":"172","author":"R Castelli","year":"2016","unstructured":"Castelli R, Wu MA, Arquati M, et al. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency. Br. J. Haematol. 2016;172:902\u2013908","journal-title":"Br. J. Haematol"},{"key":"1183_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.beha.2016.07.006","volume":"30","author":"LS Teixeira Mendes","year":"2017","unstructured":"Teixeira Mendes LS, Wotherspoon A. Marginal zone lymphoma: Associated autoimmunity and auto-immune disorders. Best Pract. Res. Clin. Haematol. 2017;30:65\u201376.","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"1183_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12032-017-1076-1","volume":"35","author":"R Castelli","year":"2018","unstructured":"Castelli R, Bergamaschini L, Deliliers GL. First-line treatment with bendamustine and rituximab, in patients with intermediate-\/high-risk splenic marginal zone lymphomas. Med. Oncol. 2018;35;15.","journal-title":"Med. Oncol"},{"key":"1183_CR9","doi-asserted-by":"publisher","first-page":"e2016030","DOI":"10.4084\/mjhid.2016.030","volume":"8","author":"R Castelli","year":"2016","unstructured":"Castelli R, Gidaro A, Deliliers GL. Bendamustine and rituximab, as first line treatment, in intermediate, high risk splenic marginal zone lymphomas of elderly patients. Mediterr J Hematol Infect Dis. 2016;8:e2016030.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"1183_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0022-1759(88)90444-9","volume":"109","author":"J Alsenz","year":"1988","unstructured":"Alsenz J, Loos M. A rapid and simple ELISA for the determination of duplicate monoclonal antibodies during epitope analysis of antigens and its application to the study of C1(-)-INH. J Immunol Methods. 1988;109:75\u201384.","journal-title":"J Immunol Methods"},{"key":"1183_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1126\/science.1198056","volume":"331","author":"DW Parsons","year":"2011","unstructured":"Parsons DW, Li M, Zhang X, et al. The genetic landscape of the childhood cancer medulloblastoma. Science. 2011;331:435\u20139.","journal-title":"Science"},{"key":"1183_CR12","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood.V89.6.2048","volume":"89","author":"V Gattei","year":"1997","unstructured":"Gattei V, Degan M, Gloghini A, et al. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood. 1997;89:2048\u201359.","journal-title":"Blood"},{"key":"1183_CR13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2015-0797","volume":"54","author":"MA Wu","year":"2016","unstructured":"Wu MA, Castelli R. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clin. Chem. Lab. Med. 2016;54:207\u2013214.","journal-title":"Clin. Chem. Lab. Med."},{"key":"1183_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.beha.2016.09.004","volume":"30","author":"V Spina","year":"2017","unstructured":"Spina V, Rossi D. Molecular pathogenesis of splenic and nodal marginal zone lymphoma. Best Pract. Res. Clin. Haematol. 2017;30:5\u201312.","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"e198","key":"1183_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3324\/haematol.2014.107680","volume":"99","author":"G Brisou","year":"2014","unstructured":"Brisou G, Verney A, Wenner T, et al. Letters to the editor: a restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders. Haematologica. 2014;99(e198):197\u20138.","journal-title":"Haematologica"},{"key":"1183_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3324\/haematol.2014.116855","volume":"100","author":"L Arcaini","year":"2015","unstructured":"Arcaini L, Rossi D, Lucioni M, et al. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection. Haematologica. 2015;100:246\u201352.","journal-title":"Haematologica"},{"key":"1183_CR17","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/1078-0432.CCR-15-1170","volume":"22","author":"V Bikos","year":"2016","unstructured":"Bikos V, Karypidou M, Stalika E, et al. An immunogenetic signature of ongoing antigen interactions in splenic marginal zone lymphoma expressing IGHV1-2*04 receptors. Clin Cancer Res. 2016;22:2032\u201340.","journal-title":"Clin Cancer Res"},{"key":"1183_CR18","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3324\/haematol.2014.119933","volume":"100","author":"E Fonte","year":"2015","unstructured":"Fonte E, Agathangelidis A, Reverberi D, et al. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation. Haematologica. 2015;100:1460\u20138.","journal-title":"Haematologica"},{"key":"1183_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.autrev.2012.08.016","volume":"12","author":"M Visentini","year":"2013","unstructured":"Visentini M, Conti V, Cristofoletti C, et al. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev. 2013;12:430\u20135.","journal-title":"Autoimmun Rev"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-018-1183-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T03:52:49Z","timestamp":1693799569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-018-1183-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1007\/s12032-018-1183-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individuals participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"118"}}